Candesartan

Brand name: Atacand

DILI Likelihood

Score C — Probable Hepatotoxin

This drug is probably linked to idiosyncratic liver injury, but has been reported uncommonly and no characteristic signature has been identified.

Fewer than 12 cases without a significant case series.

Classification

Primary class Cardiovascular

Secondary class Antihypertensive

FDA approval 1998